Latest genital herpes Stories
One Out of Every Six Americans Aged 14 to 49 Years Have Genital Herpes ANN ARBOR, Mich., Oct.
In its latest May 2014 survey, polyDNA found that 68% of respondents did not know if the same antiviral treatments are used against genital and oral herpes infections.
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes.
polyDNA recommends using Gene-Eden-VIR to protect against genital herpes. Rochester, NY (PRWEB) April 17, 2013 polyDNA’s monthly survey shows that
polyDNA answers new questions on herpes, HSV, herpes virus, genital sores, etc.
An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes.
Strains of genital herpes in Africa are far more virulent than those in the United States, researchers at Harvard Medical School report, a striking insight into a common disease with important implications for preventing HIV transmission in a region staggered by the HIV/AIDS epidemic.
Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations) episodes, suggesting a high risk of transmission from persons with unrecognized HSV-2 infection.
A study of patients attending sexual health clinics in Gothenburg found that just four out of ten patients with genital herpes actually knew that they had the disorder.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.